The FDA carefully reviewed studies and other data on Bravecto, Credelio, Nexgard and Simparica prior to approval, and these products continue to be safe and effective for the majority of animals.

The U.S. Food and Drug Administration (FDA) has issued a warning that medications in the isoxazoline class such as Bravecto, Credelio, Nexgard and Simparica may do more than just combat flea or ...

Bravecto, Nexgard and Simparica all were approved by the FDA and have been in use for about five years. Credelio recently won approval. The majority of pets treated with the products have suffered ...

They include products sold under the brand names Bravecto, Nexgard and Simparica. “Another product in this class, Credelio, recently received FDA approval. These products are approved for the ...

They include products sold under the brand names Bravecto, Nexgard and Simparica. “Another product in this class, Credelio, recently received FDA approval. These products are approved for the ...

According to the FDA, some animals receiving drugs in the isoxazoline class, including Bravecto, Nexgard and Simparica have experienced adverse events such as muscle tremors, ataxia, and seizures.

The flea and tick medicine involved in the warning are in the isoxazoline class, including Bravecto, Credelio, Nexgard, and Simparica. For more information from the FDA, click here. Karissa ...